NCT01679912
- Conditions
- Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
- Locations
-
- SAMU 93 - Hôpital Avicenne Bobigny, Île-de-France Region, France
Clinical trial condition
Hypersensitivity, Immediate
Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.
6,736 public trials
631 recruiting studies
Hypersensitivity, Immediate trial results
NCT00519636
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Long Beach, California, United States
- GSK Investigational Site Los Angeles, California, United States
NCT00539006
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Fresno, California, United States
- GSK Investigational Site Huntington Beach, California, United States
- GSK Investigational Site Long Beach, California, United States
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Mobile, Alabama, United States
- GSK Investigational Site Fresno, California, United States
NCT00502775
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Albany, Georgia, United States
- GSK Investigational Site Columbus, Georgia, United States
- GSK Investigational Site Lawrenceville, Georgia, United States
NCT02422121
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Quintiles Drug Research Unit at Guy's Hospital London, United Kingdom
Completed
Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)
NCT00163449
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Altana Pharma/Nycomed Campinas - SP, Brazil
- Altana Pharma/Nycomed Curitiba-PR, Brazil
- Altana Pharma/Nycomed Paraná, Brazil
- Altana Pharma/Nycomed Pinheiros Sao Paulo - SP, Brazil
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Fountain Valley, California, United States
- GSK Investigational Site Los Angeles, California, United States
Completed
Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131)
NCT00163345
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Altana Pharma/Nycomed RB Groningen, Netherlands
NCT00163423
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Altana Pharma/Nycomed Gmünd, Austria
- Altana Pharma/Nycomed Linz, Austria
- Altana Pharma/Nycomed Linz, Austria
- Altana Pharma/Nycomed Neusiedl/See, Austria